Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAVITOCLAX for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where NAVITOCLAX was used for Neoplasm.

Most Reported Side Effects for NAVITOCLAX

Side Effect Reports % Deaths Hosp.
Sepsis 25 14.5% 10 22
Pneumonia 24 13.9% 5 23
Thrombocytopenia 21 12.1% 8 12
Febrile neutropenia 17 9.8% 2 16
Pyrexia 16 9.3% 2 15
Fatigue 14 8.1% 2 10
Anaemia 13 7.5% 1 11
Diarrhoea 13 7.5% 2 11
Acute kidney injury 12 6.9% 5 11
Off label use 11 6.4% 10 1
Urinary tract infection 10 5.8% 1 10
Death 9 5.2% 9 3
Multiple organ dysfunction syndrome 9 5.2% 9 6
Dehydration 8 4.6% 2 6
Disease progression 8 4.6% 6 3

Other Indications for NAVITOCLAX

Myelofibrosis (58) Acute lymphocytic leukaemia (30) Acute lymphocytic leukaemia recurrent (18) Product used for unknown indication (9) Acute myeloid leukaemia (5) Malignant melanoma (5) T-cell type acute leukaemia (5)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

NAVITOCLAX Full Profile All Neoplasm Drugs NAVITOCLAX Demographics NAVITOCLAX Timeline